-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0024_06-09-2008.pdf
January 01, 2008 - manic or
depressive phases, rapid cycling, mixed states), do the typical and atypical
antipsychotic drugs … For adults experiencing a first episode of schizophrenia, do the atypical
antipsychotic drugs differ … comparative
evidence that differences in adherence or persistence among the atypical
antipsychotic drugs … developmental disorders or disruptive behavior disorders,
do the typical and atypical antipsychotic drugs … Behavioral and Psychological Symptoms of Dementia (BPSD),
do the typical and atypical antipsychotic drugs
-
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=955
July 20, 2010 - Average Outpatient Out-of-Pocket Prescription Drug Costs for the Top Five Most Expensive Prescription Drugs … Traditional Medicare did not cover prescription drugs until 2006 when Medicare Part D was phased in. … from 2005 to 2006 for adults age 65 and over for three of the top five most expensive prescription drugs … Topics:
Elderly Health Care , Health Care Costs/Expenditures , Medical Expenditures , Prescription Drugs
-
effectivehealthcare.ahrq.gov/products/indirect-comparisons/research
March 28, 2013 - research grant databases up to November 2011 to find randomized studies published in English that examined drugs … In our study, two drugs emerged as attractive because while neither had any significant chance of being … among the least safe drugs, both had greater than 50 percent chances of being among the top three drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - Trospium chloride 60
mg once daily
Placebo Esprit Pharma and
Indevus
Pharmaceuticals Inc. … (formerly Indevus
Pharmaceuticals Inc.). … Oxybutynin 2.5 mg
twice daily
Placebo Funded by Smith and
Nephew
Pharmaceuticals Ltd. … chloride Propantheline and
placebo
Pharmcia Leo
Therapeutics,
Helsingborg, Sweden
provided the
pharmaceutical … preparations used in
this study
Toglia, 201075
Study: Post-hoc Karram,
200939
VENUS
N: 739
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - Trospium chloride 60
mg once daily
Placebo Esprit Pharma and
Indevus
Pharmaceuticals Inc. … (formerly Indevus
Pharmaceuticals Inc.). … Oxybutynin 2.5 mg
twice daily
Placebo Funded by Smith and
Nephew
Pharmaceuticals Ltd. … chloride Propantheline and
placebo
Pharmcia Leo
Therapeutics,
Helsingborg, Sweden
provided the
pharmaceutical … preparations used in
this study
Toglia, 201075
Study: Post-hoc Karram,
200939
VENUS
N: 739
-
digital.ahrq.gov/ahrq-funded-projects/improving-lab-follow-delivering-enhanced-medication-list-outpatient-physician
January 01, 2023 - reminders specifically related to the patient on drug-drug interactions, drug-lab interactions, and drugs … support rules to medication history documents in selected areas, such as inadequate lab monitoring, drugs … with abnormal labs, or drugs to avoid in the elderly. … Physicians strongly agreed that medication histories helped discover drugs which were previously unknown
-
digital.ahrq.gov/health-it-tools-and-resources/health-it-costs-and-benefits-database/improving-drug-prescribing
March 01, 1984 - Purpose of Study: Increase use of generic drugs Years of study: 1979-1981 Study Design: RCT Outcomes … Intervention: Physicians were randomized to receive either a computer-generated notification for 28 common drugs … Clinical Outcomes: Generic prescribing outcomes: The authors report that the rate of use of generic drugs
-
digital.ahrq.gov/ahrq-funded-projects/assessment-pediatric-look-alike-sound-alike-lasa-substitution-errors/annual-summary/2010
January 01, 2010 - Beginning with 17,000 medications, the team eliminated LASA pairs where one of the drugs in the pair … is either IV, topical, or where the pairs represent similar drugs (e.g. extended-release versions of … These are the drugs that will be included in the Delphi process to identify pairs that are of greatest … they have identified a Food and Drug Administration file that contains cross-references for brand name drugs … with their corresponding generic names, allowing the electronic linkage of drugs that are the same but
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
April 01, 2013 - Topiramate and propranolol decreased use of drugs for acute migraine attacks. … among approved drugs. … Approved drugs were more effective than off-label
drugs except for the angiotensin II receptor blocker … or approved versus off-label drugs. … or approved versus off label drugs.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/migraine-future_research.pdf
April 01, 2013 - Topiramate and propranolol decreased use of drugs for acute migraine attacks. … among approved drugs. … Approved drugs were more effective than off-label
drugs except for the angiotensin II receptor blocker … or approved versus off-label drugs. … or approved versus off label drugs.
-
effectivehealthcare.ahrq.gov/products/migraine-prevention/research
June 11, 2013 - percent, reduction in migraine-related disability, and improvement in quality of life with off-label drugs … (No preventive drugs were approved in children.) … Also eligible were studies that compared drugs with nonpharmacologic interventions or drug management … Long-term preventive benefits are unknown both for drugs and nonpharmacologic interventions. … Future randomized trials of drugs with favorable benefits-to-harms ratio in adults are needed to identify
-
digital.ahrq.gov/sites/default/files/docs/activity/r03hs018841-basco-annual-summary-2012.pdf
January 01, 2012 - The Delphi
process identified the drugs that the participants thought to be of high potential patient … team used a Food and Drug Administration
(FDA) file that cross-referenced the brand name and generic drugs … drug pairs included in the final round of the Delphi process did not have
a person who received both drugs … For 505 pairs (83 percent), the cumulative total of subjects who received both drugs in a pair was 3,610 … project team identified 20 LASA pairs (3 percent) where greater than 1,000 subjects
received both drugs
-
effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
June 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists the single topic for which (1) preliminary phase III data for drugs (or … Frustratingly, an
unusually high percentage of investigational drugs have not met primary endpoints
-
psnet.ahrq.gov/web-mm/milliliters-vs-milligrams
September 01, 2004 - Similarly, expensive drugs can be prepared in patient-specific doses by extracting multiple doses from … While less optimal, some drugs can be dispensed in the manufacturer's packaging along with instructions … Examples of medications not requiring pharmacy individualization might include inexpensive drugs with … ), and drugs accessed by nurses from automated dispensing machines within the patient care units (e.g … Any cost–benefit analysis should include an evaluation of the cost of pharmaceuticals, personnel costs
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1506.pdf
June 01, 2015 - health care sector, horizon
scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures … Information is compiled for expert comment on topics at a granular
level (i.e., similar drugs in the … Results
The table below lists the single topic for which (1) preliminary phase III data for drugs (or … Frustratingly, an
unusually high percentage of investigational drugs have not met primary endpoints
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
August 05, 2010 - Patients with osteoarthritis also use over-the-counter
supplements not regulated by the FDA as pharmaceuticals … Pharmacokinetics, Indications, and Dosing of drugs to be included. … Oral drugs (trade names provided only for drugs under patent)
Drug (any trade name): acetaminophen … Non-steroidal anti-inflammatory
drugs. … Non-steroidal anti-inflammatory
drugs for low-back pain.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoarthritis-pain_research-protocol.pdf
August 05, 2010 - Patients with osteoarthritis also use over-the-counter
supplements not regulated by the FDA as pharmaceuticals … Pharmacokinetics, Indications, and Dosing of drugs to be included. … Oral drugs (trade names provided only for drugs under patent)
Drug (any trade name): acetaminophen … Non-steroidal anti-inflammatory
drugs. … Non-steroidal anti-inflammatory
drugs for low-back pain.
-
meps.ahrq.gov/data_files/publications/st43/sb43.xml
July 01, 2004 - 1987 and 2001
Marie Stagnitti, MPA and Mamatha Pancholi, MS
Highlights
Prescribed drugs … Total annual expenditures for prescribed drugs reported by households to treat mental health conditions …
In 1987, prescribed drugs reported as purchased to treat mental heath disorders ranked sixth … In 2001, prescription drugs reported as purchased to treat arthritis fell to eighth in the ranking of …
Prescribed drugs reported as purchased to treat high blood pressure ranked highest in terms
-
meps.ahrq.gov/data_files/publications/cb16/cb16.shtml
March 01, 2006 - •
Section 2: Population Subgroups
•
Foreword
•
Section 3: Therapeutic Classes of Drugs … Nearly half (45%) of the total spending for outpatient prescription drugs was paid by patients and their … The five therapeutic classes of drugs accounting for the largest expenses in the community population … Section 3 contains expenses on outpatient prescription drugs by therapeutic class. … Drugs were assigned to therapeutic
classes by linking HC-077A to the Multum Lexicon database, a
-
meps.ahrq.gov/data_files/publications/st21/stat21.shtml
January 01, 2003 - In 1997, outpatient prescription drugs accounted for approximately 13% of total health expenditures ( … Over the same period, the average expenditure for prescription drugs for those age 65 and older with … a purchase was significantly higher than the average expenditure for prescription drugs for those under … Between 1997 and 2000, the aggregate total utilization of outpatient prescription drugs significantly … Average Expenditure for Outpatient Prescription Drugs for Those With a Purchase by Age, 1997-2000